These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 23034325)

  • 1. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.
    Fernández L; Hancock RE
    Clin Microbiol Rev; 2012 Oct; 25(4):661-81. PubMed ID: 23034325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efflux drug transporters at the forefront of antimicrobial resistance.
    Rahman T; Yarnall B; Doyle DA
    Eur Biophys J; 2017 Oct; 46(7):647-653. PubMed ID: 28710521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial Multidrug Efflux Pumps of the Major Facilitator Superfamily as Targets for Modulation.
    Kumar S; He G; Kakarla P; Shrestha U; Ranjana KC; Ranaweera I; Willmon TM; Barr SR; Hernandez AJ; Varela MF
    Infect Disord Drug Targets; 2016; 16(1):28-43. PubMed ID: 27052334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations.
    Sun J; Deng Z; Yan A
    Biochem Biophys Res Commun; 2014 Oct; 453(2):254-67. PubMed ID: 24878531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intrinsic resistance of bacteria.
    Zhang G; Feng J
    Yi Chuan; 2016 Oct; 38(10):872-880. PubMed ID: 27806928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
    Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
    Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of drug resistance in bacteria: efflux pump modulation for designing of new antibiotic enhancers.
    Mohanty H; Pachpute S; Yadav RP
    Folia Microbiol (Praha); 2021 Oct; 66(5):727-739. PubMed ID: 34431062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Outer Membrane Permeability Favor Drug-Resistant Phenotype of Klebsiella pneumoniae.
    Pulzova L; Navratilova L; Comor L
    Microb Drug Resist; 2017 Jun; 23(4):413-420. PubMed ID: 27526080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive drug resistance mediated by root-nodulation-cell division efflux pumps.
    Daniels C; Ramos JL
    Clin Microbiol Infect; 2009 Jan; 15 Suppl 1():32-6. PubMed ID: 19220351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of a Potent Multidrug Efflux Pump Variant That Enhances Campylobacter Resistance to Multiple Antibiotics.
    Yao H; Shen Z; Wang Y; Deng F; Liu D; Naren G; Dai L; Su CC; Wang B; Wang S; Wu C; Yu EW; Zhang Q; Shen J
    mBio; 2016 Sep; 7(5):. PubMed ID: 27651364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003.
    Chevalier J; Mulfinger C; Garnotel E; Nicolas P; Davin-Régli A; Pagès JM
    PLoS One; 2008 Sep; 3(9):e3203. PubMed ID: 18787654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux.
    Van Bambeke F; Pagès JM; Lee VJ
    Recent Pat Antiinfect Drug Discov; 2006 Jun; 1(2):157-75. PubMed ID: 18221142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efflux pumps as interventions to control infection caused by drug-resistance bacteria.
    Farhat N; Ali A; Bonomo RA; Khan AU
    Drug Discov Today; 2020 Dec; 25(12):2307-2316. PubMed ID: 33011344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive resistance in bacteria requires epigenetic inheritance, genetic noise, and cost of efflux pumps.
    Motta SS; Cluzel P; Aldana M
    PLoS One; 2015; 10(3):e0118464. PubMed ID: 25781931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efflux pump inhibitors for bacterial pathogens: From bench to bedside.
    Sharma A; Gupta VK; Pathania R
    Indian J Med Res; 2019 Feb; 149(2):129-145. PubMed ID: 31219077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view.
    Lynch AS
    Biochem Pharmacol; 2006 Mar; 71(7):949-56. PubMed ID: 16290174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural extracts stimulate membrane-associated mechanisms of resistance in Gram-negative bacteria.
    Fadli M; Chevalier J; Hassani L; Mezrioui NE; Pagès JM
    Lett Appl Microbiol; 2014 May; 58(5):472-7. PubMed ID: 24447247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
    Nikaido H; Pagès JM
    FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA).
    Shu JC; Chia JH; Siu LK; Kuo AJ; Huang SH; Su LH; Wu TL
    Int J Antimicrob Agents; 2012 Mar; 39(3):217-22. PubMed ID: 22079532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.